Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

BIOTRONIK Applauded by Frost & Sullivan for its Disruptive Implantable Cardiac Monitoring Device, BIOMONITOR IIIm - The BIOMONITOR IIIm improves patient outcomes with its clinically actionable ECGs, superior features, and high precision - Biotronik.com / Frost.com
BIOTRONIK Applauded by Frost & Sullivan for its Disruptive Implantable Cardiac Monitoring Device, BIOMONITOR IIIm

 

PRZOOM - /newswire/ - London, United Kingdom, 2021/07/28 - The BIOMONITOR IIIm improves patient outcomes with its clinically actionable ECGs, superior features, and high precision - Biotronik.com / Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Based on its recent analysis of the Global market for implantable cardiac monitoring devices, Frost & Sullivan recognizes BIOTRONIK with the 2021 Global Enabling Technology Leadership Award. The company’s subcutaneous miniature, injectable electrocardiogram (ECG) device, BIOMONITOR IIIm, enhances patient outcomes with its highly accurate ECG, temperature, and activity measurement. The device’s unique BIOvector design optimizes the signal quality to generate high-definition ECGs and ensure maximum precision in the recorded rhythm disturbance.

“The BIOMONITOR IIIm allows physicians to monitor cardiac patients’ irregular heart rhythm, temperature, and activity remotely,” said Dr. M. Sneha Maria, Senior Research Analyst. “Used with the BIOTRONIK Home Monitoring® solution, it enables patients’ recorded cardiac rhythm disturbance to be automatically and wirelessly transmitted to physicians. The solution enables 24-hour monitoring from anywhere, helping it achieve a transmission compliance rate of 98%, the highest in the industry. Such efficacy is useful, especially during the COVID-19 pandemic, as physicians can continually monitor patients for warning signs without hospital visits. Frost & Sullivan believes that BIOMONITOR IIIm, with the high precision and industry-leading battery life, will disrupt the implantable cardiac home monitoring market.”

The BIOMONITOR IIIm’s battery life of five and a half years allows it to record, store, and transmit heart rhythm irregularities for an extended period, compared to competitive implantable cardiac monitoring devices. Moreover, the device employs RhythmCheck, an intelligent algorithm that recognizes ectopic beats and eliminates approximately 72% of false positive detections arising from ectopic beats. The innovative algorithm adapts to each patient’s unique heart rhythm, resulting in higher accuracy than competing implantable cardiac monitoring devices.

BIOMONITOR IIIm can be used to diagnose and monitor several cardiac arrhythmia conditions, such as atrial fibrillation, bradycardia, sudden drops in heart rate, high ventricular rate, and asystole. The RhythmCheck algorithm endows the device with 99.1% sensitivity to atrial fibrillation episodes and 100% sensitivity to episodes of high ventricular rate, bradycardia, asystole, and sudden drops in heart rate. Moreover, the device measures patients’ temperature and activity rate so physicians can identify warning signs early and initiate timely and appropriate interventions.

“Being an insertable device, it enables patients to carry on with their routine activities and is safe around most household electronic appliances. Patients are allowed to record additional ECGs after suspicious events so physicians can correlate symptoms with the heart rhythm. The CardioReport’s ‘traffic light system’ also supports alert-based patient care and efficient triage,” noted Dr. Maria. “Overall, its ability to remotely transmit accurate and clinically actionable data to physicians decreases clinicians’ workload and improves patients’ quality of life, resulting in exceptional ownership and service experience to both physicians and patients.”

Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that both enhances current products and enables the development of new products and applications. The award recognizes the high market acceptance potential of the recipient’s technology.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

About BIOTRONIK

BIOTRONIK (biotronik.com) is a leading medical device company that has been developing trusted and innovative cardiovascular and endovascular solutions for more than 50 years. Driven by a purpose to perfectly match technology with the human body, BIOTRONIK innovations deliver care that saves and improves the lives of millions diagnosed with heart and blood vessel diseases every year. BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries.

Contact:
Sarah Lahert, BIOTRONIK Corporate Public Relations & Communications
P: +49(0) 30 68905 1414 - E: press[.]biotronik.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


BIOTRONIK Applauded by Frost & Sullivan for its Disruptive Implantable Cardiac Monitoring Device, BIOMONITOR IIIm

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
BIOMONITOR | Frost & Sullivan
Contact: Kristen Moore - Frost.com 
+1 210-247-3823 kristen.moore[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Medical Services / Equipment Most Recent Related Press Releases:

Bruker Launches the Q4 POLO - Compact Spark-OES Metals Analyzer
Respiratory Health Management Market to Expedite Digital, Smart, and Portable Solutions Says Frost & Sullivan
Bruker Joins PANACEA Network to Broaden Access to NMR for European Chemistry Community
High-end Global Computed Tomography Purchases to Propel the High-end CT Segment Revenue Finds Frost & Sullivan
KRAIBURG TPE Introduces Ergonomically Designed Healthcare Equipment
Fujifilm Lauded by Frost & Sullivan for Disrupting the Operating Room Space with its Systems Integration Solution
BASF’s Irgastab® Enables LOTTE Chemical to Deliver High-clarity Medical Polypropylene for Syringes Used in COVID-19 Vaccinations
Withings and One Drop Partner to Bring Best-in-class Medical Devices to Multi-condition Employer Program
Sensor Technologies for Pressure Injury Prevention Improve Outcomes and Operational Efficiency for Hospitals Finds Frost & Sullivan
New Bruker NMR Life Science Research Solutions Enable Functional Structural and Cellular Biology Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  JobsWare.com

Visit  RightITnow, Inc.

Visit  Limelon Advertising, Co.







 
  ©2021 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today